Smith & Nephew RENASYS Soft Port REF: 66800799 (The RENASYS Soft Port Dressing Kits are used in...
FDA Device Recall #Z-1157-2014 — Class II — January 9, 2014
Recall Summary
| Recall Number | Z-1157-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 9, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Smith & Nephew Inc. |
| Location | Saint Petersburg, FL |
| Product Type | Devices |
| Quantity | 162,629 invididual units |
Product Description
Smith & Nephew RENASYS Soft Port REF: 66800799 (The RENASYS Soft Port Dressing Kits are used in conjunction with negative pressure wound therapy pumps)
Reason for Recall
Reports of wound fluid and /or blood that were not evacuated from beneath the wound dressing and the pump blockage alarm did not activate has been associated with inadequate Soft Port sealing at the wound site or improper positioning of the Soft Port orifice over the wound contact dressing drape. Inadequate sealing can result in air leaks and contribute to inefficient fluid evacuation from the wo
Distribution Pattern
Worldwide Distribution-USA (nationwide) including Puerto Rico and the states of AK, AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, KY, LA, MA, MS, MT, NC, NJ, NV, NY, OH, OR, PA, TN, TX, VA, WA, WI, WV, HI and the countries Dubai, Curacao, Argentina, Australia, Chile, Germany, France, England, Hong Kong, Kuwait, Lebanon, Libya, Sri Lanka, Malaysia, New Zealand, Manila, Saudi Arabia, South Africa, Singapore, Turkey, Taipei and Vietnam.
Lot / Code Information
ALL LOT #s 2013010311 and lower
Other Recalls from Smith & Nephew Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0581-2025 | Class II | BIORAPTOR Suture Anchors. Tendon/ligament, non-... | Oct 29, 2024 |
| Z-3097-2024 | Class II | ROTATION MEDICAL TENDON STAPLES (8) (narrow in... | Aug 12, 2024 |
| Z-3096-2024 | Class II | ROTATION MEDICAL TENDON STAPLES (8) (broad indi... | Aug 12, 2024 |
| Z-1162-2014 | Class II | Smith & Nephew RENASYS-AB Abdominal Dressing K... | Jan 9, 2014 |
| Z-1158-2014 | Class II | Smith & Nephew RENASYS-F Foam Dressing Kit wit... | Jan 9, 2014 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.